Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT00574327)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT00574327 Sponsor: Midwest Biomedical Research Foundation Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT00574327 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be a patient eligible for care at the Kansas City VA Hospital, where this study is taking place.
You have been diagnosed with Barrett's esophagus (a condition affecting the lining of the food pipe), with or without abnormal cell changes, or you have acid reflux disease (these would be the "cases" group).
Alternatively, you are having an endoscopy (a camera examination of the digestive tract) for other reasons such as anemia, unexplained weight loss, or diarrhea, but you do not have acid reflux disease or Barrett's esophagus (these would be the "controls" group).

Who may not be able to join:

You have serious, uncontrolled health conditions affecting your heart, lungs, kidneys, liver, or metabolism that are not well managed.
You are taking blood-thinning medications (such as warfarin or similar drugs) that could make taking small tissue samples (biopsies) more risky.
You are unable to provide your own medical history for any reason.
You have dyspepsia (persistent stomach discomfort or indigestion).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prateek Sharma, MD, Department of Veterans Affairs Medical Center of Kansas City

Phone: 816-861-4700

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00574327

Sponsor: Midwest Biomedical Research Foundation

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

Trial contact: 816-861-4700

More information: https://clinicaltrials.gov/study/NCT00574327

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be a patient eligible for care at the Kansas City VA Hospital, where this study is taking place.
You have been diagnosed with Barrett's esophagus (a condition affecting the lining of the food pipe), with or without abnormal cell changes, or you have acid reflux disease (these would be the "cases" group).
Alternatively, you are having an endoscopy (a camera examination of the digestive tract) for other reasons such as anemia, unexplained weight loss, or diarrhea, but you do not have acid reflux disease or Barrett's esophagus (these would be the "controls" group).

Who may not be able to join:

You have serious, uncontrolled health conditions affecting your heart, lungs, kidneys, liver, or metabolism that are not well managed.
You are taking blood-thinning medications (such as warfarin or similar drugs) that could make taking small tissue samples (biopsies) more risky.
You are unable to provide your own medical history for any reason.
You have dyspepsia (persistent stomach discomfort or indigestion).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Midwest Biomedical Research Foundation

Registry

ClinicalTrials.gov

Start date

1 January 2006

Est. completion

1 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The goal of this study is to follow GERD and BE pts prospectively for development of dysplasia and adenocarcinoma, to identify factors responsible for progression of GERD to BE to dysplasia and adenocarcinoma.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov